Kyntra Bio (KYNB) Income Statement
Kyntra Bio Income Statement
Last quarter (Q2 2026), Kyntra Bio's total revenue was $-1.47M, a decrease of 209.35% from the same quarter last year. In Q2, Kyntra Bio's net income was $11.97M. See Kyntra Bio’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 6.44M | $ 29.62M | $ 46.80M | $ 140.73M | $ 235.31M | |
| $ 5.88M | $ 14.06M | $ 42.84M | $ 120.45M | $ -213.88M | |
| $ 51.78M | $ 164.48M | $ 365.56M | $ 421.48M | $ 74.65M | |
| Depreciation and Amortization | $ 748.00K | $ 2.69M | $ 9.93M | $ 10.60M | $ 14.81M |
| $ -57.55M | $ -142.43M | $ -305.20M | $ -282.82M | $ -333.72M | |
| $ -45.90M | $ -150.42M | $ -322.72M | $ -301.02M | $ -288.53M | |
| $ -12.40M | $ -2.95M | $ -501.00K | $ 7.73M | $ -1.15M | |
| $ -58.29M | $ -153.37M | $ -323.22M | $ -293.30M | $ -289.68M | |
| $ 183.45M | $ -47.58M | $ -284.23M | $ -293.65M | $ -290.02M | |
| Per Share Metrics | |||||
| Basic EPS | $ 45.37 | $ -0.48 | $ -2.92 | $ -3.15 | $ -3.15 |
| Diluted EPS | $ 45.37 | $ -0.48 | $ -2.92 | $ -3.15 | $ -3.15 |
| Weighted Average Shares Outstanding | 4.04M | 4.00M | 3.89M | 3.74M | 3.69M |
| Weighted Average Shares Outstanding (Diluted) | 4.04M | 4.00M | 3.89M | 3.74M | 3.69M |
Currency in USD
